[Asia Economy Reporter Lee Seon-ae] Incon, a company specializing in integrated CCTV control systems, surged to the upper limit early in trading on the 22nd and is currently showing a rise of over 24%. This marks a consecutive two-day rally following news of its U.S. subsidiary's plan to list on Nasdaq.
As of 9:37 a.m. on the 22nd, Incon was trading at 1,705 KRW, up 24%. The price soared to the maximum limit of 29.82% early in the session, hitting the upper limit. Incon also closed at the upper limit the previous day, with a sharp increase of 29.72%.
The previous day, it was reported that Incon's U.S. subsidiary, Zyber Therapeutics, signed a merger agreement with Raksper Health Acquisition, a special purpose acquisition company (SPAC) listed on Nasdaq, and that after the merger, it will be traded on Nasdaq.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

![Clutching a Stolen Dior Bag, Saying "I Hate Being Poor but Real"... The Grotesque Con of a "Human Knockoff" [Slate]](https://cwcontent.asiae.co.kr/asiaresize/183/2026021902243444107_1771435474.jpg)